# Israeli blood test detects early breast cancer with 95% accuracy

> **Open Intelligence Dossier** · First detected: 2026-11-12 01:00 UTC · Category: Health

## Executive Summary
Israeli researchers developed a blood test that detects early breast cancer with 95% accuracy and predicts recurrence risk using epigenetic signatures on cell-free nucleosomes.

## Intelligence Brief
The research, led by scientists at the Hebrew University of Jerusalem and Hadassah Medical Center, uses an epigenetic liquid biopsy approach that profiles histone modifications on cell-free nucleosomes circulating in blood.


The study extensively profiled epigenetic heterogeneity in treatment-naive human luminal breast tumours obtained directly after surgical resection. Using a single-cell epigenetic approach based on cytometry by time-of-flight, researchers identified a recurrent subpopulation of basal-like cells within luminal tumours that carries a conserved epigenetic signature across patients. These basal-like cells, also identified through deconvolution of whole-genome DNA methylation patterns, are characterized by high expression of aggressive oncogenic traits and downregulation of hormone receptor signalling.


Direct comparison of single-cell proteomic and genomic profiling revealed that monomethylation and trimethylation of histone 3 on lysine 4 (H3K4me1 and H3K4me3) are key features associated with loss of luminal identity. The researchers highlighted the potential of concomitant single-molecule profiling of these histone modifications on cell-free nucleosomes in blood as an epigenetic liquid biopsy approach for early diagnosis. Moreover, the epigenetic basal signature measured in blood is linked to prognosis, enabling identification of patients at increased risk for disease relapse.


Breast cancer remains the most diagnosed cancer among women and is stratified by gene expression patterns into luminal and basal-like subtypes, with basal-like associated with worse prognosis. Recent advances in single-cell technologies have underscored intratumour heterogeneity, which poses substantial challenges for treatment and long-term disease-free survival. The new test addresses this by detecting the epigenetic signature of aggressive basal-like cells that may be present even in luminal tumours, potentially catching hidden threats that could cause cancer to return.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo | Breast cancer blood test spots hidden threat that could cause it to return | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxNTnJuNGdEQkdDTUpPZE5MSFJ0WFh2NkdOYTJXb1BXQ053WHlRZlZTdnZPeTE5VjhFVnNIQlY2QTJuSjcyUjNEa3JkOXh6RVY1S3huZFA4MzBwYVZERTUzN3RLczdhc2hSX1pzVFJPcEpRMl9rR1FRVEFUSGVJUWZqdTBlcWgzTXBXWmtaaWhpbkZxeHc?oc=5) |
| Newsweek | Breast Cancer Blood Test Spots Hidden Threat That Could Cause It To Return | [Source Link](https://news.google.com/rss/articles/CBMirAFBVV95cUxNN0ZBbVZYOXJoQlBKQ2hUOUZYRXM5SXBqdVNFemtRaS1kdm1kd21mdVJReHpCZ0tPN3c5QnpBdzVrRWJFVGMyTHdWSF9JNkJobEdsLTRfY3Z5YkVoWEJLUnBaYWVmbDlQWEQ5SFVXOUxMenl5WXdVc2FhWFd3dnlUTEN2S2xEVHhaVzg0OVdfODZzLXc3T0pZQTlaU3NtaWtVNGRLMHdQNEM0cmpp?oc=5) |
| Medical Xpress | Experimental blood test detects early breast cancer and predicts recurrence | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxQaTRBWml2SjJuVGtSb1lnblRjRjBIWXBpYlV4RFk0amNyZU5JVFM1M2p0YkJ3Zk1Lajl0Q3BmNGI2MTZUUFdQRUI1SGZZNy1vVWFndm1hNXZkUTd0QkphRm53Sjh1RDZ4UlZuYmJKTTdSME9NSXYxUzEyVG5aU1hsSElBSV91V3VWMWc?oc=5) |
| J-Wire | Blood test shows promise in detecting early breast cancer and predicting recurrence | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxOWDBXZHVldkk1Nks5NS1sdmRLM01aMmxLZER2Z3BUUk9XZDVPWHJodjJKR0ZpX3ZIX2VMRDhrcERDamJDc1VFMEI3NFlUTXpvXzY5bHU1Smd6a2dRa3RmdTB1ZGx3YnF5VjB2QzZSaDV5T0hvT3dvUmVxMTRUQ3Itb3RDNUxVZk54aXVxQVpZTDh5aV9YUk4wQ0o1R21uOG5EYmJhZkQxTzVFZWh0Ync?oc=5) |
| ThinkPol | Blood test spots early breast cancer and flags who is likely to relapse, study finds | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxNdjltWU9QWnNkaXJsTWhMYzc0Z1lzdXRqZi1Bai1jVVFxckg5eE9mOVJLNXlWU0trcXVucEdzSXE3RTJsOXlqbFdMWWN4bmRPMzROeHhTTmVucXJ4RFp0aEVsTUo4TFNJRVFYNWRtY0VsWUpQM1B3NzRkMUhoOVpRX0NILTlTRzBUV3NVRlFWTGpzRmtobnZrSkpoWnU4U1NfQ3FHU0VuNmp5WUMyb05iZWlha1lvZw?oc=5) |
| Bioengineer.org | Epigenetic Blood Test Detects Early Breast Cancer and Recurrence Risk | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOUzJEVkZ5TFRfbGpEWG1xaEV4aGUzZ1RhY3BEdUNmV1Q0VXNtZjRjNG93UmNJZTdCWnZjbThvaWZjRXpCQkltVXVZRG15ODhXa2NueGFEQW9GWmFtMlJydkdPZVRYb1VfdUNiQngwWk1YeHI0MXRpb2s1UnhhbjFSY3pHSnBXM1NLOThIOHhpZDdyTUJaMVRDdDBR?oc=5) |
| Qazinform | New blood test detects early breast cancer with 95% accuracy, study finds | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxOUmhaQ1FTSnVncmU5RVJuQmhZOHFRTng5WmFHSjlmZHNQV1F4dlNtYzVSS3ZKVkE4RG5LQ2lLOTJSYUpWeThXdEVQeDg4RFgweUsxeXREZENGempMN0Rta0JaMGNVdDNqbzM4bEstQW5scWEwOElrSW5CdEl2NEtHeGlqd3psVVgwb3hxTWZNVmpPR0lYTm1ETEU5bGVwaF9LUFZaOVNUWVTSAagBQVVfeXFMUHBZUXh2Vk41dTZOdmRMbUdKNHluZ3didE5Fa0Y0cnVlN2Z0WEltc0dBSDh1QVlEZFdLYXdyY3ExRnZQR3ppbUtWYVc2bXhMVnZTazlmdGtLWGhqRVFFY2ZhQnk4UGhUcUVoQVpOM0QtQWRRYjNNT2pwWkFBdGxra2hsTW5rZ1YzLTBRT2JsQXR0a3dWVjY5c1o5OG1NZmVyNm5HeGFneEk0?oc) |
| Azərtac | Researchers develop blood test to detect early-stage breast cancer, predict recurrence | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxNU3NmZHl1ZkFVX2FZd2ROWG12WHFxTkxxN005R05PcHRyNjZKaldVOWFNM0hfNWZNakZCT2RKZURUbHMtbEFKQ0VUM2VjalVLZ09taHRZeEllUktFLVREMVNVU3BEdVZMWElMLVRUai1vVzdIczBReGhhcE1sYVNIZ0RBWlQydWg5X2FJM0VTTEJuVEg0ZFduTHNSSmhrSGFzV19TcWRKQXo2X3JGWGw4LTVIb2dieGRFTGM5STF3?oc=5) |
| Vietnam.vn | Blood tests help detect breast cancer early and predict the risk of recurrence. | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxOVUdETm8zUEJia3BJZUc4QVRfSkZjXzZrUjcxQXhKZEFHTjdaR3ZlNUh1VW1OYlNtTV9rRkNFMkJyaTV0UmNZZHVadE90VzF0RUtBLU1tcVUzUVFrQjNwNmZzUnJDeHNCbE5FTXY3NFdtY0YtZUIyX0ZrampkcjJBcF9UbU50bVFqN253YkFubDZxUFN4bHk5YTkwaVVCYm8?oc=5) |
| Ynetnews | New Israeli blood test detects early breast cancer, predicts risk of recurrence | [Source Link](https://news.google.com/rss/articles/CBMiakFVX3lxTFBZU1dlSk9NRTZOSUdoNkVXT1p1akk1UGsyQW55TmsxamM5YVgwTDFrZ1VGNHY5YU9IN0RnVHZjWlpBakZTd3ZDQU95UkNNdElRZ2ZtY01XRC1aU1ZhbkNwXy1uNzgwdzk0TkE?oc=5) |
| GenomeWeb | Blood Nucleosome Epigenetic Signature May Improve Breast Cancer Diagnosis, Prognosis | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxNSkYwWGwzWE1XM3VMNjVoR0hJbHUyX1ZySkRVTVF5cDJlckZoSTQ4UzRoX2ppQkVsdXhJSUhHaEVVZ3JmUXZORy16MTlZWlJzcmU5b2tJb043R0dHa200RmZaTzd2UGxQSE1qT2NoRUpCMmVlWHpEdVVqWkRZdlljbkpHUDQ3TVlEUzFRQlM3R2wyaEJOaENsRkNMWlVuZU9aeUxF?oc=5) |
| Nature | Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmd0xfSDVzcU1HNk5SOG9BVmk3TTdreWpCNzh5b2U1WTVfWHpTQms3bV9BOHEzM1ZzU2VIc0xnNmhTRHJwQWxORk1xWUdkaXl3SHV2OURmcGNld2pvTXdJ?oc=5) |
| The Times of Israel | Israeli blood test detects early breast cancer with 95% accuracy | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxORXlYTXBmcmxQdjdsX1RRamlHU2hadUMtRlkwSGphWC03NGwybF9GVXFuUlZ4WG1tNml1WS01XzF3NjlFLTJaWjZJTms5aWJZbjJTQWRobmU2UV94TUZyTUF6aFBmekRtcXdXZXUwWmYwcWgxWlBQSVplRTJNWmpjR24zdTF5Z0Zuc1JIUEZwUU91bHFuTERSLWZ30gGfAUFVX3lxTE5Gamo3QXhZRnl2SlBYVmE1UFRIdFY4bnZpRENQR2ZPT2V4MjZJT2VEN2NaVG1SQVEtZFpOTmdvNUFoTU8xaWdzN2RBYlR4VVBiQVFZc0NmLXhEdzVKdHIyLU5Zc1ZLVW9uMGJtR3BTY2Q1NDZ3bTY5dDlXM3djc1E3dEVLakpiV3AxNEhjdmdrZ3J4cnVmbDNMRi0tZktacw?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-11-12/israeli-blood-test-detects-early-breast-cancer-with-95-accuracy*
